재발한 두경부암에서 라다클로린을 이용한 광역동치료 = Photodynamic Therapy for Recurrent Head and Neck Malignancy

다국어 초록 (Multilingual Abstract)

Background and Objectives As a preliminary study, authors tried to verify clinical and side effects of Radachlorin in a photodynamic therapy for recurrent head and neck malignancy. Radachlorin shows an absorption peak at 662 nm, which indicates that it penetrates up to 10 mm.
Subjects and Method We treated 12 sites for 9 treatments in 6 recurrent head and neck malignacies, 4 cases of squamous cell cancers and each of adenoid cystic cancer, and undifferentiated nasopharyngeal cancer. A dose of 1 mg/kg or 2-5 mL of Radachlorin was i.v. injected into the mass according to the mass size. We used a diode laser, MILON-662 (Milon Laser Company, Russia) and Medlight cylindrical 10/20 radial diffuser and frontal diffuser as light delivery devices. About 3 hrs after intravenous injection, or 30 min after intralesional injection, a light dose of 200-300 J/cm2 or cm of laser was irradiated onto the tumor or intralesionally with the light dose of 200-300 J/cm2, or cm.
Results There was partial tumor regression in three of the five primary tumors. In one case of metastatic node treated by intralesional injection and irradiation, tumor showed complete necrosis. But there was no effect in 2 cases of subcutaneous metastases. There were no side effects such as fever, chill and photosensitivity in any of the cases.
Conclusion The clinical effect of photodynamic therapy (PDT) using Radachlorin with 662 nm of laser light is not clear yet, but it seems to be a safe treatment for head and neck malignancy. We need to investigate the effect of this PDT system in untreated head and neck malignancies.

참고문헌 (Reference)

1 Schweitzer VG, "Photofrin mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies" 29 (29): 305-313, 2001

2 Biel MA, "Photodynamic therapy treatment of early oral and laryngeal cancers" 83 (83): 1063-1068, 2007

3 Filonenko EV, "Photodynamic therapy of early esophageal cancer" 5 (5): 187-190, 2008

4 Lee YS, "Photodynamic therapy in head and neck malignancy" 15 : 214-221, 2004

5 Rigual NR, "Photodynamic therapy for head and neck dysplasia and cancer" 135 (135): 784-788, 2009

6 Uzdensky AB, "Photodynamic effect of novel chlorin e6 derivatives on a single nerve cell" 74 (74): 2185-2197, 2004

7 Su-Mi Bae, "Photodynamic Effects of Radachlorin on Cervical Cancer Cells" 대한암학회 36 (36): 389-394, 2004

8 Boucher Y, "Interstitial pressure gradients in tissue-isolated and subcutaneous tumors:implications for therapy" 50 (50): 4478-4484, 1990

9 Lou PJ, "Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer" 91 (91): 441-446, 2004

10 Gutmann R, "Interstitial hypertension in head and neck tumors in patients:correlation with tumor size" 52 (52): 1993-1995, 1992

11 Douillard S, "In vitro evaluation of Radachlorin sensitizer for photodynamic therapy" 98 (98): 128-137, 2010

12 Prialov VA, "Five Years’ Experience of Photodynamic Therapy with New Chlorin Photosensitizer.In Therapeutic Laser Applications and Laser-Tissue Interactions II; 2005 Aug 19; Munich,Germany" (5863) : 186-198, 2005

13 Prialov VA, "Clinical Trials of a New Chlorin Photosensitizer for Photodynamic Therapy of Malignant Tumors.In Optical methods for tumor treatment and detection:Mechanisms and technologies in Photodynamic therapy XI; 2002 Jan 19; San Hose Califonia" 4612 : 178-189, 2002